Podcast: Opportunities for biotechs in precision medicine, driving value and bringing important new therapies to patients

March 4, 2020 PAREXEL

Within the past 20 years, the field of precision medicine has been transformed. For biotech companies, this new landscape holds tremendous promise for innovation. So, why aren’t more companies leveraging this approach? In this episode, Parexel precision medicine experts Angela Qu and Arlene Hughes join host Alberto Grignolo to discuss this conundrum, and what biotechs should be thinking about right from the start, to open up the opportunity for this approach to help bring innovation and new therapies to more patients.  

Previous Article
The Parexel Podcast | Episode 6: The opportunity for biotechs in precision medicine
The Parexel Podcast | Episode 6: The opportunity for biotechs in precision medicine

Within the past 20 years, the field of precision medicine has been transformed. For biotech co...

Next Article
Drug development innovations that work: Precision medicine
Drug development innovations that work: Precision medicine

Learn more about new regulatory frameworks for precision medicine and how best to demonstrate results for r...

Contact Us with your Biotech needs!

Email Us